Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma

Journal of the National Cancer Institute

Volumn 88, Issue 17, 1996, Pages 1222-1227

  Thorban, Stefan ^a   Roder, Jürgen D ^a   Nekarda, Hjalmar ^a   Funk, A ^a   Siewert, J Rüdiger ^a   Pantel, Klaus ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN;

ADULT; AGED; ARTICLE; BONE MARROW METASTASIS; CLINICAL TRIAL; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE;

EID: 0029761679     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.17.1222     Document Type: Article

References (30)

1. Ajani JA. Therapy of carcinoma of the oesophagus: either attempt it not or succeed. Eur J Cancer 1995;31A:790-3.
2. Siewert JR, Roder JD. Lymphadenectomy in esophageal cancer surgery. Dis Esophagus 1992;5:91-7.
3. Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994; 81:410-3.
4. Mansi JL, Berger U, McDonnell T, Pople A, Rayter Z, Gazet JC, et al. The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 1989; 7:445-9.
5. Schlimok G, Funke I, Holzmann B, Gottlinger G, Schmidt G, Hauser H, et al. Micrometastic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad Sci U S A 1987;84:8672-6.
6. Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 1991;9:1749-56.
7. Dearnaley DP, Sloane JP, Ormerod MG, Steele K, Coombes RC, Clink HM, et al. Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer 1981;44:85-90.
8. Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmuller G. Prognostic significance of micrometastic tumour cells in bone marrow of colorectal cancer cells. Lancet 1992;340:685-9.
9. Moss TJ, Reynolds CP, Sather HN, Romansky SG, Hammond GD, Seeger RC. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 1991;324:219-26.
10. Pantel K, Izbicki JR, Angstwurm M, Braun S, Passlick B, Karg O, et al. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 1993;53:1027-31.
11. Schlimok G, Funke I, Pantel K, Strobel F, Lindemann F, Witte J, et al. Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 1991;27:1461-5.
12. Hermanek P. What's new in TNM? Pathol Res Pract 1994;190:97-102.
13. Debus E, Weber K, Osborn M. Monoclonal cytokeratin antibodies that distinguish simple from stratified squamous epithelia: characterization on human tissues. EMBO J 1982; 1:1641-7.
14. Viac J, Reano A, Brochier J, Staquet MJ, Thivolet J. Reactivity pattern of monoclonal antikeratin antibody (KL1). J Invest Dermatol 1983;81:351-4.
15. Karsten U, Papsdorf G, Roloff G, Stolley P, Abel H, Walther I. et al. Monoclonal anticytokeratin antibody from a hybridoma clone generated by electrofusion. Eur J Cancer Clin Oncol 1985;21:733-40.
16. Kasper M, Stosiek P, Typlt H, Karsen U. Histological evaluation of three new monoclonal anti-cytokeratin antibodies. I. Normal tissues. Eur J Cancer Clin Oncol 1987;23:137-47.
17. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald Z, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monocloncal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32:219-29.
18. Diel IJ, Kaufmann M, Goerner R, Costa SD, Kaul S, Bastert G. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 1992;10:1534-9.
19. Harrison WJ. The total cellularity of the bone marrow in man. J Clin Pathol 1962;15:254-9.
20. Burkhardt R, Frisch B, Kettner G. The clinical study of micro-metastatic cancer by bone biopsy. Bull Cancer (Paris) 1980;67:291-305.
21. Pantel K, Schlimok G, Angstwurm M, Weckermann D, Schmaus W, Gath H, et al. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 1994;3:165-73.
22. Anderson LL, Lad TE. Autopsy findings in squamous-cell carcinoma of the esophagus. Cancer 1982;50:1587-90.
23. Mandard AM, Chasle J, Marnay J. Villedieu B, Bianco C, Roussel A, et al. Autopsy findings in 111 cases of esophageal cancer. Cancer 1981;48:329-35.
24. Bosch A, Frias Z, Caldwell WL, Jaeschke WH. Autopsy findings in carcinoma of the esophagus. Acta Radiol Oncol Radiat Phys Biol 1979;18:103-12.
25. Schoenfeld A, Luqmani Y, Smith D, O'Reilly S, Shousha S, Sinnett HD, et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 1994;54:2986-90.
26. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 1994;12:475-82.
27. Traweek ST, Liu J, Battifora H. Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am J Pathol 1993;142:1111-8.
28. Pantel K, Izbicki J, Passlick B, Angstwurm M, Haussinger K, Thetter O, et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 1996;347:649-53.
29. Pantel K, Schlimok G, Braun S, Kutter D, Lindemann F, Schaller G, et al. Differential expression of proliferation-associated molecules in individual micrometastic carcinoma cells. J Natl Cancer Inst 1993;85:1419-24.
30. Riethmuller G, Schneider-Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K, et al. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group [see comment citation in Medline]. Lancet 1994;343:1177-83.